|
|
Other links at Articles > Cardiology |
| 1. |
FDA Recommends Withdrawal of Midodrine
|
|
|
The FDA is recommending the withdrawal of midodrine hydrochloride, currently used in the treatment of hypotension, because there are insufficient data to support its benefit. Heartwire
|
| 2. |
ON-TIME 2: Pre-Hospital Tirofiban Beneficial in STEMI
|
|
|
In patients with ST-segment elevation myocardial infarction needing primary percutaneous coronary intervention, tirofiban improved ST-segment resolution without a significant increase in bleeding. Medscape Medical News
|
|
|